

浏览全部资源
扫码关注微信
1.络病理论创新转化全国重点实验室,石家庄 050035
2.河北以岭医药研究院,国家中医药管理局重点研究室(心脑血管络病),石家庄 050035
3.河北以岭医院,吴以岭名老中医药专家传承工作室,石家庄 050090
Received:26 August 2023,
Published Online:28 November 2023,
Published:20 March 2024
移动端阅览
尹玉洁,常丽萍,魏聪.络病理论指导恶性肿瘤癌因性疲乏理论探讨[J].中国实验方剂学杂志,2024,30(06):211-217.
YIN Yujie,CHANG Liping,WEI Cong.Theoretical Exploration of Cancer-related Fatigue in Malignant Tumors Guided by Luobing Theory[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(06):211-217.
尹玉洁,常丽萍,魏聪.络病理论指导恶性肿瘤癌因性疲乏理论探讨[J].中国实验方剂学杂志,2024,30(06):211-217. DOI: 10.13422/j.cnki.syfjx.20232446.
YIN Yujie,CHANG Liping,WEI Cong.Theoretical Exploration of Cancer-related Fatigue in Malignant Tumors Guided by Luobing Theory[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(06):211-217. DOI: 10.13422/j.cnki.syfjx.20232446.
癌因性疲乏患者易伴有厌食、减重、腹胀等症状或体征,严重降低生存质量,成为影响恶性肿瘤患者生存率的独立危险因素,亟需寻找有效的治疗策略及药物。既往基于络病理论指导提出“改善证候——肿瘤治疗新策略”学术观点,笔者以气络学说核心理论“承制调平”为指导,提出恶性肿瘤癌因性疲乏“脾肾两虚,瘀毒内阻”中医病机及“健脾益肾、化瘀解毒”治法,研制的代表药物养正消积胶囊不仅对实体瘤有良好的治疗作用,在治疗癌因性疲乏方面也显示出良好优势,有助于恢复恶性肿瘤患者“荷瘤生存”自稳平衡状态,为癌因性疲乏临床治疗提供新的药物选择。
Patients with cancer-related fatigue are prone to symptoms and signs such as anorexia, weight loss, and abdominal distension, which seriously reduces the quality of life and becomes an independent risk factor affecting the survival rate of patients with malignant tumors. Therefore, it is urgent to find effective treatment strategies and drugs. In the past, the academic viewpoint of improving syndromes—a new strategy for tumor treatment was proposed based on the guidance of the Luobing theory. Based on this, this article proposes the pathogenesis of cancer-related fatigue is characterized by spleen and kidney deficiency, stasis and toxin internal obstruction, as well as the treatment method of strengthening the spleen and tonifying the kidney, resolving blood stasis and detoxification guided by the core theory of the Qiluo doctrine of Chengzhi Tiaoping. The representative drug Yangzheng Xiaoji capsules has been developed, not only has good therapeutic effect on solid tumors, but also shows good advantages in treating cancer-related fatigue, which can help to restore the homeostasis of tumor bearing survival in patients with malignant tumors and provide new drug choices for the clinical treatment of cancer-related fatigue.
WORLD HEALTH ORGANIZATION . Global health estimates(GHE) 2020 [EB/OL].( 2020-02-04 )[ 2023-08-25 ]. https://www.who.int/healthinfo/global_burden_disease/en/ https://www.who.int/healthinfo/global_burden_disease/en/ .
刘宗超 , 李哲轩 , 张阳 , 等 . 2020全球癌症统计报告解读 [J]. 肿瘤综合治疗电子杂志 , 2021 , 7 ( 2 ): 1 - 14 .
曹毛毛 , 陈万青 . 中国恶性肿瘤流行情况及防控现状 [J]. 中国肿瘤临床 , 2019 , 46 ( 3 ): 145 - 149 .
李涛 , 柴培培 , 张毓辉 , 等 . 我国肿瘤治疗费用核算与筹资负担分析 [J]. 卫生经济研究 , 2021 , 38 ( 7 ): 17 - 20 .
魏聪 , 袁国强 , 常丽萍 , 等 . 改善证候——肿瘤治疗新策略 [J]. 中医杂志 , 2014 , 55 ( 7 ): 555 - 557 .
BERGER A M , MITCHELL S A , JACOBSEN P B , et al . Screening,evaluation,and management of cancer-related fatigue:Ready for implementation to practice? [J]. CA Cancer J Clin , 2015 , 65 ( 3 ): 190 - 211 .
NATIONAL COMPREHENSIVE CANCER NETWORK . NCCN Clinical Practice Guidelines in Oncology:Cancer Related Fatigue(2020) [M]. Version 2.Bethesda : NCCN , 2020 : 15 .
HORNEBER M , FISCHER I , DIMEO F , et al . Cancer-related fatigue:Epidemiology,pathogenesis,diagnosis,and treatment [J]. Dtsch Arztebl Int , 2012 , 109 ( 9 ): 161 - 171 .
WANG X S , ZHAO F M , FISCH M J , et al . Prevalence and characteristics of moderate to severe fatigue:A multicenter study in cancer patients and survivors [J]. Cancer , 2014 , 120 ( 3 ): 425 - 432 .
张剑军 , 钱建新 . 中国癌症相关性疲乏临床实践诊疗指南(2021年版) [J]. 中国癌症杂志 , 2021 , 31 ( 9 ): 852 - 872 .
《中成药治疗优势病种临床应用指南》标准化项目组 . 中成药治疗癌因性疲乏临床应用指南(2020年) [J]. 中国中西医结合杂志 , 2021 , 41 ( 5 ): 534 - 541 .
BERGER A M , MOONEY K , ALVAREZ-PEREZ A , et al . Cancer-Related Fatigue,Version 2.2015 [J]. J Natl Compr Cane Netw , 2015 , 13 ( 8 ): 1012 - 1039 .
BREEN D M , KIM H , BENNETT D , et al . GDF-15 neutralization alleviates platinum-based chemotherapy-induced emesis,anorexia,and weight loss in mice and nonhuman primates [J]. Cell Metab , 2020 , 32 ( 6 ): 938 - 950 .
REEVE B B , MITCHELL S A , DUECK A C , et al . Recommeded patient-reported core set of symptoms to measure in adult cancer treatment trials [J]. J Natl Cancer Inst , 2014 , 106 ( 7 ): dju129 .
VAN LANCKER A , VELGHE A , VAN HECKE A , et al . Prevalence of symptoms in older cancer patients receiving palliative care:A systematic review and Meta-analysis [J]. J Pain Symptom Manage , 2014 , 47 ( 1 ): 90 - 104 .
李增宁 , 李晓玲 , 陈伟 , 等 . 肿瘤患者食欲评价和调节的专家共识 [J]. 肿瘤代谢与营养电子杂志 , 2020 , 7 ( 2 ): 169 - 177 .
ZHOU T , YANG K X , THAPA S , et al . Validation of the Chinese version of functional assessment of anorexia-cachexia therapy(FAACT) scale for measuring quality of life in cancer patients with cachexia [J]. Support Care Cancer , 2017 , 25 ( 4 ): 1183 - 1189 .
宋春花 , 王昆华 , 郭增清 , 等 . 中国常见恶性肿瘤患者营养状况调查 [J]. 中国科学:生命科学 , 2020 , 50 ( 12 ): 1437 - 1452 .
ROHM M , ZEIGERER A , MACHDO J , et al . Energy metabolism in cachexia [J]. EMBO Rep , 2019 , 20 ( 4 ): e47258 .
GORDON P , LEGRAND S B , WALSH D . Nausea and vomiting in advanced cancer [J]. Eur J Pharmacol , 2014 , 722 : 187 - 191 .
VON HAEHLING S , ANKER S D . Cachexia as major underestimated and unmet medical need:Facts and numbers [J]. Int J Cardiol , 2012 , 161 ( 3 ): 121 - 123 .
LAVIANO A , MEGUID M M , ROSSI-FANELLI F . Cancer anorexia:Clinical implications,pathogenesis,and therapeutic strategies [J]. Lancet Oncol , 2003 , 4 ( 11 ): 686 - 694 .
KAMEN C , TEJANI M A , CHANDWANI K , et al . Anticipatory nausea and vomiting due to Chemotherapy [J]. Eur J Pharmacol , 2014 , 722 : 172 - 179 .
BARSEVICK A , BECK S L , DUDLEY W N , et al . Efficacy of an intervention for and sleep disturbance during cancer chemotherapy [J]. J Pain Symptom Manage , 2010 , 40 ( 2 ): 200 - 216 .
DONOVAN K A , JACOBSEN P B , ANDRYKOWSKI M A , et al . Course of fatigue in women receiving chemotherapy and/or radiotherapy for early stage breast cancer [J]. J Pain Symptom Manage , 2004 , 28 ( 4 ): 373 - 380 .
WILLIAMS L A . Clinical management of symptom clusters [J]. Semin Oncol Nurs , 2007 , 23 ( 2 ): 113 - 120 .
国家药品监督管理局药品审评中心 . 关于发布《与恶性肿瘤治疗相关中药新药复方制剂临床研发技术指导原则(试行)》的通告(2023年第30号) [EB/OL].( 2023-04-14 )[ 2023-08-25 ]. https://www.cde.org.cn/main/news/viewInfoCommon/53fe81056937a6029663b48280a972c6 https://www.cde.org.cn/main/news/viewInfoCommon/53fe81056937a6029663b48280a972c6 .
吴以岭 . 气络——NEI网络相关性探析 [J]. 中医杂志 , 2005 , 46 ( 10 ): 723 - 726 .
吴以岭 , 魏聪 , 赵珊珊 . 气与气络学说探讨 [J]. 中医杂志 , 2017 , 58 ( 21 ): 1801 - 1807 .
吴以岭 . 气络学说论——《气络论》序 [J]. 疑难病杂志 , 2018 , 17 ( 2 ): 184 - 186 .
郑红刚 , 侯炜 , 花宝金 . 调气解毒法的学术内涵及其在肿瘤防治中的实践 [J]. 中医杂志 , 2022 , 63 ( 21 ) : 2023 - 2028,2036 .
杨婧妍 , 张钟玥 , 王苏晋 , 等 . 从虚劳论治恶性肿瘤化疗后骨髓抑制 [J]. 湖南中医药大学学报 , 2021 , 41 ( 5 ): 779 - 782 .
JIANG W G , YE L , RUGE F , et al . Expression of sonic hedgehog(SHH) in human lung cancer and the impact of Yangzheng Xiaoji on SHH-mediated biological function of lung cancer cells and tumor growth [J]. Anticancer Res , 2015 , 35 ( 3 ): 1321 - 1331 .
JIANG W G , YE L , RUGE F , et al . Yangzheng Xiaoji exerts anti‑tumour growth effects by antagonising the effects of HGF and its receptor,cMET,in human lung cancer cells [J]. J Transl Med , 2015 , 13 : 280 .
邢力刚 , 赵汉玺 , 李贵新 , 等 . 晚期肺癌养正消积胶囊联合化疗临床对照研究 [J]. 中华肿瘤防治杂志 , 2014 , 21 ( 5 ): 384 - 386 .
李雯 , 杜雅冰 , 冯堃 , 等 . 养正消积胶囊联合心理干预治疗胃癌晚期疗效及对患者生活质量、情绪的影响 [J]. 陕西中医 , 2019 , 40 ( 6 ): 722 - 725 .
孙波 , 胡雪玲 . 化疗联合养正消积胶囊治疗中晚期大肠癌临床研究 [J]. 中医学报 , 2017 , 32 ( 9 ): 1586 - 1588 .
温晓雅 , 刘志强 , 王博龙 . 养正消积胶囊联合铂类化疗方案治疗非小细胞肺癌的Meta分析 [J]. 湖北民族大学学报:医学版 , 2020 , 37 ( 1 ): 20 - 24 .
苏连明 , 李海林 , 王加良 . 养正消积胶囊减轻胃癌术后化疗不良反应的临床观察 [J]. 中国药房 , 2014 , 25 ( 7 ): 657 - 659 .
许进秀 , 李鲁明 , 徐红燕 , 等 . 养正消积胶囊对晚期消化道肿瘤患者生活质量及证候影响 [J]. 中华中医药学刊 , 2018 , 36 ( 3 ): 535 - 537 .
孙波 , 胡雪玲 . 化疗联合养正消积胶囊治疗中晚期大肠癌临床研究 [J]. 中医学报 , 2017 , 32 ( 9 ): 1586 - 1588 .
李邦凯 , 纪浩南 , 王馨 , 等 . 养正消积胶囊辅助GP方案治疗晚期非小细胞肺癌临床研究 [J]. 中国中医药信息杂志 , 2019 , 26 ( 8 ): 12 - 17 .
卢泰成 , 许博文 , 邬金洋 , 等 . 从“免疫编辑”角度探讨恶性肿瘤的五期演变生物学基础 [J]. 中国实验方剂学杂志 , 2023 , 29 ( 21 ): 172 - 179 .
严丹 , 杨杨 , 李春姗 . 养正消积胶囊对胃癌术后化疗患者细胞免疫功能和不良反应的影响 [J]. 中国民族民间医药 , 2016 , 25 ( 21 ): 105 - 106 .
何斌 , 刘建平 , 孙红 , 等 . Ⅰ~Ⅲ期结直肠癌西医常规治疗后中医干预指南 [J]. 中国实验方剂学杂志 , 2023 , 29 ( 21 ): 1 - 9 .
王岩 , 卢艳龙 . 养正消积胶囊辅助治疗晚期结肠癌患者的疗效及安全性研究 [J]. 现代中西医结合杂志 , 2016 , 25 ( 27 ): 3044 - 3047 .
宋媛媛 , 许鹏 , 杨晨光 , 等 . 养正消积胶囊对癌因性疲乏患者的影响 [J]. 天津中医药大学学报 , 2016 , 35 ( 4 ): 238 - 241 .
毕俊芳 , 李雪松 , 边莉 , 等 . 养正消积胶囊改善癌症恶病质研究 [J]. 现代中西医结合杂志 , 2016 , 25 ( 12 ): 1290 - 1292 .
肖祖林 , 任真 , 叶思思 , 等 . 养正消积胶囊联合化疗治疗非小细胞肺癌的疗效及安全性的Meta分析 [J]. 中药新药与临床药理 , 2020 , 31 ( 6 ): 735 - 740 .
张立双 , 金鑫瑶 , 张俊华 , 等 . 养正消积胶囊联合化疗治疗消化道恶性肿瘤疗效和安全性的Meta分析 [J]. 中国循证医学杂志 , 2018 , 18 ( 1 ): 59 - 66 .
徐婉琳 . 扶正解毒汤治疗脾气虚弱型消化道恶性肿瘤化疗患者癌因性疲乏的临床研究 [D]. 广州 : 广州中医药大学 , 2022 .
冷玉玲 , 吴勇 , 周先阳 , 等 . 培土固本灸治疗消化道恶性肿瘤化疗相关性癌因性疲乏的疗效观察 [J]. 中华全科医学 , 2021 , 19 ( 9 ): 1565 - 1568 .
陈梦利 . 消化道恶性肿瘤癌因性疲乏的中医临床特征分析及督灸干预后疗效观察 [D]. 郑州 : 河南中医药大学 , 2022 .
0
Views
79
下载量
2
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621